Anti-Ly-6G monoclonal antibody as a protective strategy against ischemia–reperfusion injury in free skin flaps: An experimental rat study

نویسندگان
doi
10.48309/jmpcr.2026.559013.1891
چکیده

Ischemia–reperfusion (I/R) injury is a major contributor to partial or total flap necrosis in reconstructive surgery. Neutrophils play a central role in the destructive inflammatory cascade. Blocking leukocyte adhesion with monoclonal antibodies may limit tissue injury and improve flap survival. Sixteen adult Wistar rats underwent elevation of a 4 × 6 cm inferior epigastric skin flap. The vascular pedicle was clamped for 8 hours to induce ischemia, followed by 48 hours of reperfusion. Fifteen minutes before reperfusion, the treatment group received Ly-6G monoclonal antibody (0.20 mg/kg IV). Flap survival was assessed by digital planimetry. Neutrophil infiltration, superoxide dismutase (SOD) activity, and caspase-3 activity were evaluated. Ly-6G significantly enhanced flap viability (mean 84%) compared to untreated ischemic controls (mean ~9%). Neutrophil counts were markedly reduced. SOD activity was preserved, while caspase-3 activity was significantly decreased (p < 0.05). Pre-reperfusion administration of Ly-6G monoclonal antibody protects skin flaps from I/R injury by inhibiting neutrophil adhesion, reducing oxidative stress, and suppressing apoptosis. This targeted immunologic approach may represent a valuable adjunct in microsurgical reconstruction .